98%
921
2 minutes
20
The resurgence of pertussis over the past decades has resulted in incidence levels not witnessed in the United States since the 1950s. The underlying causes have been the subject of much speculation, with particular attention paid to the shortcomings of the latest generation of vaccines. We formulated transmission models comprising competing hypotheses regarding vaccine failure and challenged them to explain 16 years of highly resolved incidence data from Massachusetts, United States. Our results suggest that the resurgence of pertussis is a predictable consequence of incomplete historical coverage with an imperfect vaccine that confers slowly waning immunity. We found evidence that the vaccine itself is effective at reducing overall transmission, yet that routine vaccination alone would be insufficient for elimination of the disease. Our results indicated that the core transmission group is schoolchildren. Therefore, efforts aimed at curtailing transmission in the population at large, and especially in vulnerable infants, are more likely to succeed if targeted at schoolchildren, rather than adults.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063734 | PMC |
http://dx.doi.org/10.1126/scitranslmed.aaj1748 | DOI Listing |
Infect Drug Resist
August 2025
Department of Child Health Care, Children's Hospital, Zhejiang University School of Medicine, National Children's Regional Medical Center, National Children's Regional Medical Center, National Clinical Research Center for Child Health, Hangzhou, Zhejiang, People's Republic of China.
Background: Pertussis is a highly contagious respiratory disease caused by Bordetella pertussis, posing a significant health threat to children. Despite vaccination efforts, a resurgence of pertussis has been observed globally, especially during and after the COVID-19 pandemic. This study aims to investigate the epidemiological trends and characteristics of pertussis among pediatric patients during and after the COVID-19 pandemic in East China.
View Article and Find Full Text PDFIJID Reg
September 2025
Department of Infectious Diseases, Okayama University Hospital, Okayama, Japan.
Pertussis, a highly contagious respiratory infection caused by , has demonstrated a global resurgence in the post-COVID-19 era, with the emergence of macrolide-resistant strains. In Japan, the routine immunization schedule for pertussis remains limited compared with international standards, leaving young populations under-immunized and at elevated risk of infection. Despite international recommendations for booster vaccinations during adolescence, Japan currently provides only a four-dose primary series during infancy, without subsequent boosters.
View Article and Find Full Text PDFVaccines (Basel)
August 2025
School of Public Health and Health Sciences, California State University, Dominguez Hills, Carson, CA 90747, USA.
: The whole cell pertussis vaccine was introduced in the United States in the 1940s and switched to the acellular pertussis vaccine partially in 1992 and completely in 1997. This study examines the relationship between the resurgence of pertussis in the United States and the change in the type of pertussis vaccines. : Pertussis cases from 1922 to 2024 were obtained from the CDC's national notifiable disease surveillance system, and vaccination coverage was obtained from the WHO.
View Article and Find Full Text PDFVaccines (Basel)
July 2025
Institute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.
Background: Despite decades of high childhood vaccination coverage, pertussis has re-emerged in the Autonomous Province of Vojvodina (AP Vojvodina), Serbia. We aimed to describe the temporal, seasonal, and age-specific patterns of pertussis in AP Vojvodina and to analyze trends by vaccination status in order to highlight changes in epidemiology and potential gaps in vaccine-induced protection.
Methods: We retrospectively analyzed 2796 pertussis cases reported between January 1997 and December 2024, examining temporal, seasonal, and age-specific trends, stratifying by vaccination status across four consecutive periods (1997-2003, 2004-2010, 2011-2017, and 2018-2024).
Microorganisms
August 2025
Laboratory of Microbiology and Biological Bank, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.
Since late 2023, an increase in infections has been noticed in Europe, particularly among children. Our data showed the upward trend of cases in the Lazio region, even among adults with severe influenza-like illnesses, highlighting the necessity for maintaining high vaccination rates across both children and adults. These findings underscore the urgent need for clinicians to maintain a high index of suspicion for in patients with respiratory symptoms, prioritize nasopharyngeal swabs for accurate diagnosis, assess for co-infections, verify booster vaccination status in adults, and support timely reporting to public health authorities.
View Article and Find Full Text PDF